Previous Close | 12.39 |
Open | 12.53 |
Bid | 15.57 x N/A |
Ask | 15.64 x N/A |
Day's Range | 12.53 - 12.53 |
52 Week Range | 7.58 - 15.16 |
Volume | |
Avg. Volume | 0 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Elanco stock surged Wednesday after the pet drugmaker beat first quarter expectations and hiked its profit guidance for the year.
Although the revenue and EPS for Elanco Animal Health (ELAN) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Comprehensive Analysis of Elanco's Financial Performance and Updated Guidance